[
    "{\"step_by_step_thinking\": \"Raloxifene is a selective estrogen receptor modulator (SERM) that is used to prevent osteoporosis in postmenopausal women. It has estrogenic effects on bone and anti-estrogenic effects on the uterus and breast. Therefore, it does not increase the risk of breast cancer. However, like estrogen, raloxifene increases the risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism. It does not increase the risk of cellulitis or hypercholesterolemia.\", \"answer_choice\": \"A. Pulmonary embolism\"}"
]